Explore the words cloud of the ELEVATE project. It provides you a very rough idea of what is the project "ELEVATE" about.
The following table provides information about the project.
|Coordinator Country||Belgium [BE]|
|Total cost||3˙999˙310 €|
|EC max contribution||3˙301˙990 € (83%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2019-01-01 to 2023-12-31|
Take a look of project's partnership.
|1||UNIVERSITEIT GENT||BE (GENT)||coordinator||1˙518˙835.00|
|2||UNIVERSIDADE NOVA DE LISBOA||PT (LISBOA)||participant||419˙850.00|
|3||LABMAN AUTOMATION LIMITED||UK (MIDDLESBROUGH CLEVELAND)||participant||395˙420.00|
|4||UNIVERSITAT ROVIRA I VIRGILI||ES (TARRAGONA)||participant||341˙802.00|
|5||UNIVERSIDAD DE CUENCA||EC (CUENCA)||participant||259˙900.00|
|6||FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.||DE (MUNCHEN)||participant||214˙577.00|
|7||microLIQUID sl||ES (Arrasate-Mondragon)||participant||151˙605.00|
|8||CONSORCIO DE INVESTIGACION SOBRE VIH SIDA TB CISIDAT||MX (CUERNAVACA MORELOS)||participant||0.00|
|9||FUNDACAO PIO XII||BR (BARRETOS)||participant||0.00|
Cervical cancer is the 4th most common cancer in women worlThe ELEVATE project sets a multidisciplinary team comprising manufactures and experts from Europe and the Community of Latin American and Caribbean States, to improve the global adequacy and coverage of cervical cancer screening, particularly to specific populations of women that by not being regularly screened (hard-to-reach populations) are at higher-risk to develop cervical cancer. Although Cervical cancer is still the fourth most common cancer in women worldwide, with up to 85% of the burden occurring in developing countries, preventive vaccination against human papillomavirus and early detection of precancer in screening programs has shown to be successful in reducing cancer incidence and mortality.1–3 However, different challenges hamper a global implementation of such programs and are in the base of women’s non-attendance to screening. This highlights the lack of reflection of ethnic, cultural and resource differences from different populations in current cervical cancer screening. In ELEVATE it is proposed to conduct social science investigations to identify hard-to-reach women in Belgium, Brazil, Ecuador and Portugal, to address their barriers to screening and to design strategies to make primary screening more accessible to them, and therefore, contribute to reduce the global burden of cervical cancer. This will be complemented with fundamental and technological research to develop an efficient and marketable test for the combined genomic and proteomic detection of high-risk HPV infections in those populations. The test will be made portable, low-cost, compatible with self-sampling, point-of-care and generate rapid and easy-to-understand results, without relying on electrical outlets or trained health personnel. Integrant part of the proposal is also to infer and disseminate the societal, economic implications of the developed strategies using a hard-to-reach community-based participatory research.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ELEVATE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ELEVATE" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
Global Alliance for Chronic Diseases SecretariatRead More
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More